Ignite Creation Date:
2025-12-24 @ 6:32 PM
Ignite Modification Date:
2025-12-24 @ 6:32 PM
Study NCT ID:
NCT05163457
Status:
COMPLETED
Last Update Posted:
2022-03-10
First Post:
2021-12-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Prevalence of Frailty Among People Aged 75 and Over Living at Home
Sponsor:
Université de Reims Champagne-Ardenne
Organization:
Study Overview
Official Title:
Prevalence of Frailty Among People Aged 75 and Over Living at Home
Status:
COMPLETED
Status Verified Date:
2022-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
FRAIL-DOM
Brief Summary:
The aging of population lead to study ways to prevent dependence. Frailty is a precursor to dependence which can be reversible. In the literature, estimate of prevalence of frailty is highly variable depending on the frailty definition, the population studied and the screan tool used. In fact, many scales to measure frailty have emerged without gold standard.
The SEGAm showed its usefulness in aged patients living at home.
The SEGAm showed its usefulness in aged patients living at home.
Detailed Description:
The aim of the study is to describe prevalence of frailty in patients aged of 75 and more living at home.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: